{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:31:10Z","timestamp":1792758670360,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clp.2024.10.008","type":"journal-article","created":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T07:29:41Z","timestamp":1734766181000},"page":"115-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Neonatal Cytomegalovirus Infection"],"prefix":"10.1016","volume":"52","author":[{"given":"Ashley","family":"Stark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea M.","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Elizabeth Dew","family":"Weimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clp.2024.10.008_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.clp.2024.10.008_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1016\/j.clp.2024.10.008_bib3","first-page":"1","article-title":"Cytomegalovirus infection in pregnancy: review of the literature","volume":"5","author":"Bonalumi","year":"2011","journal-title":"J\u00a0Prenat Med"},{"issue":"6","key":"10.1016\/j.clp.2024.10.008_bib4","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2016.02.042","article-title":"Diagnosis and antenatal management of congenital cytomegalovirus infection","volume":"214","author":"Hughes","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clp.2024.10.008_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"issue":"9","key":"10.1016\/j.clp.2024.10.008_bib6","doi-asserted-by":"crossref","first-page":"e606","DOI":"10.1542\/neo.22-9-e606","article-title":"Congenital cytomegalovirus infection: epidemiology, timely diagnosis, and management","volume":"22","author":"Jenks","year":"2021","journal-title":"NeoReviews"},{"issue":"8","key":"10.1016\/j.clp.2024.10.008_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20736","article-title":"Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening: a systematic review and meta-analysis","volume":"4","author":"Ssentongo","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.clp.2024.10.008_bib8","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciq085","article-title":"Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection","volume":"52","author":"Wang","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.clp.2024.10.008_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/pd.4118","article-title":"A\u00a0series of 238 cytomegalovirus primary infections during pregnancy: description and outcome","volume":"33","author":"Picone","year":"2013","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.clp.2024.10.008_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s12884-021-03979-z","article-title":"Changing knowledge, attitudes and behaviours towards cytomegalovirus in pregnancy through film-based antenatal education: a feasibility randomised controlled trial of a digital educational intervention","volume":"21","author":"Calvert","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.clp.2024.10.008_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2018.04.043","article-title":"Racial and ethnic differences in the prevalence of congenital cytomegalovirus infection","volume":"200","author":"Fowler","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"10","key":"10.1016\/j.clp.2024.10.008_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8101516","article-title":"Congenital cytomegalovirus infection: update on diagnosis and treatment","volume":"8","author":"Chiopris","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.clp.2024.10.008_bib13","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejpn.2022.01.019","article-title":"The long-term burden of congenital cytomegalovirus: Hospitalisation and mortality in a population-based matched cohort study","volume":"37","author":"Smithers-Sheedy","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"issue":"Suppl 4","key":"10.1016\/j.clp.2024.10.008_bib14","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jcv.2009.08.019","article-title":"Newborn screening for congenital cytomegalovirus: options for hospital-based and public health programs","volume":"46","author":"Grosse","year":"2009","journal-title":"J\u00a0Clin Virol"},{"issue":"6","key":"10.1016\/j.clp.2024.10.008_bib15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.clinthera.2019.04.022","article-title":"The economic burden of congenital cytomegalovirus disease in the first year of life: a retrospective analysis of health insurance claims data in the United States","volume":"41","author":"Meyers","year":"2019","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.clp.2024.10.008_bib16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2128","article-title":"A\u00a0targeted approach for congenital cytomegalovirus screening within newborn hearing screening","volume":"139","author":"Fowler","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.clp.2024.10.008_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2021.151393","article-title":"Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies","volume":"45","author":"Grosse","year":"2021","journal-title":"Semin Perinatol"},{"issue":"5","key":"10.1016\/j.clp.2024.10.008_bib18","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0002-9378(88)90252-9","article-title":"Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants","volume":"158","author":"Yow","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.clp.2024.10.008_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240172","article-title":"Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring","volume":"15","author":"Demmler-Harrison","year":"2020","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clp.2024.10.008_bib20","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.clp.2024.10.008_bib21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/INF.0000000000003671","article-title":"Breast milk and saliva for postnatal Cyto\u2020megalovirus screening among very low birth Weight infants","volume":"41","author":"Mukhopadhyay","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clp.2024.10.008_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000004492","article-title":"Concordance of CMV saliva and urine testing in infants for the detection of congenital infection","author":"Stark","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.clp.2024.10.008_bib23","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jpeds.2015.10.069","article-title":"Symptomatic congenital cytomegalovirus infection is underdiagnosed in british columbia","volume":"169","author":"Sorichetti","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clp.2024.10.008_bib24","author":"National"},{"key":"10.1016\/j.clp.2024.10.008_bib25","author":"Administration"},{"key":"10.1016\/j.clp.2024.10.008_bib26","author":"Pesch"},{"issue":"14","key":"10.1016\/j.clp.2024.10.008_bib27","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.2010.423","article-title":"Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection","volume":"303","author":"Boppana","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clp.2024.10.008_bib28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/JCM.01391-07","article-title":"Evaluation of different cytomegalovirus (CMV) DNA PCR protocols for analysis of dried blood spots from consecutive cases of neonates with congenital CMV infections","volume":"46","author":"Soetens","year":"2008","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.clp.2024.10.008_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2180-8-2","article-title":"External quality assessment of cytomegalovirus DNA detection on dried blood spots","volume":"8","author":"Barbi","year":"2008","journal-title":"BMC Microbiol"},{"issue":"3","key":"10.1016\/j.clp.2024.10.008_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.5441","article-title":"Sensitivity of dried blood spot testing for detection of congenital cytomegalovirus infection","volume":"175","author":"Dollard","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.clp.2024.10.008_bib32","author":"Marie Pigeon"},{"issue":"6","key":"10.1016\/j.clp.2024.10.008_bib33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/528376","article-title":"Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease","volume":"197","author":"Kimberlin","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.clp.2024.10.008_bib34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/516445","article-title":"Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of allergy and infectious diseases collaborative antiviral study group","volume":"175","author":"Whitley","year":"1997","journal-title":"J\u00a0Infect Dis"},{"issue":"1","key":"10.1016\/j.clp.2024.10.008_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J\u00a0Pediatr"},{"issue":"Suppl 4","key":"10.1016\/j.clp.2024.10.008_bib36","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jcv.2009.08.012","article-title":"Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system","volume":"46","author":"Oliver","year":"2009","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.clp.2024.10.008_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.113945","article-title":"Valganciclovir in infants with hearing loss and clinically inapparent congenital cytomegalovirus infection: a nonrandomized controlled trial","author":"Chung","year":"2024","journal-title":"J\u00a0Pediatr"},{"issue":"10","key":"10.1016\/j.clp.2024.10.008_bib38","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJMoa1404599","article-title":"Valganciclovir for symptomatic congenital cytomegalovirus disease","volume":"372","author":"Kimberlin","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.clp.2024.10.008_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/archdischild-2015-309154","article-title":"Hearing outcome of infants with congenital cytomegalovirus and hearing impairment","volume":"101","author":"Bilavsky","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.clp.2024.10.008_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.113934","article-title":"Oral valganciclovir initiated beyond one month of age as treatment of sensorineural hearing loss caused by congenital cytomegalovirus infection: a randomized clinical trial","author":"Kimberlin","year":"2024","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.clp.2024.10.008_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/archdischild-2018-316010","article-title":"Economic cost of congenital CMV in the UK","volume":"104","author":"Retzler","year":"2019","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.clp.2024.10.008_bib43","first-page":"57","article-title":"Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.clp.2024.10.008_bib44","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.ijporl.2015.09.019","article-title":"Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection","volume":"79","author":"Bergevin","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.clp.2024.10.008_bib45","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1542\/peds.2011-1444","article-title":"Attitudes toward newborn screening for cytomegalovirus infection","volume":"128","author":"Din","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.clp.2024.10.008_bib46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3476(99)70328-8","article-title":"Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?","volume":"135","author":"Fowler","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.clp.2024.10.008_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1044\/2015_AJA-15-0007","article-title":"Is early intervention effective in improving spoken language outcomes of children with congenital hearing loss?","volume":"24","author":"Ching","year":"2015","journal-title":"Am J Audiol"},{"issue":"12","key":"10.1016\/j.clp.2024.10.008_bib48","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamapediatrics.2016.2016","article-title":"Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection","volume":"170","author":"Gantt","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"12","key":"10.1016\/j.clp.2024.10.008_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.23949","article-title":"Estimated cost-effectiveness of newborn screening for congenital cytomegalovirus infection in China using a markov model","volume":"3","author":"Chen","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.clp.2024.10.008_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28391","article-title":"The cost-effectiveness of maternal and neonatal screening for congenital cytomegalovirus infection in Japan","volume":"95","author":"Aoki","year":"2023","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.clp.2024.10.008_bib51","series-title":"Vaccines for the 21st century: a tool for decisionmaking","article-title":"The National Academies collection: Reports funded by National Institutes of health","year":"2000"},{"issue":"Suppl 2","key":"10.1016\/j.clp.2024.10.008_bib52","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.vaccine.2023.06.020","article-title":"Vaccine value profile for cytomegalovirus","volume":"41","author":"Boppana","year":"2023","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.clp.2024.10.008_bib53","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.vaccine.2018.01.042","article-title":"Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France","volume":"36","author":"N'Diaye","year":"2018","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.clp.2024.10.008_bib54","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1016\/j.vaccine.2012.04.011","article-title":"Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus","volume":"30","author":"Dempsey","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.clp.2024.10.008_bib55","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1902","article-title":"Human papillomavirus vaccine effectiveness and herd protection in young women","volume":"143","author":"Spinner","year":"2019","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2024.10.008_bib57","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1093\/infdis\/jiz402","article-title":"Review of mathematical models of vaccination for preventing congenital cytomegalovirus infection","volume":"221","author":"Lanzieri","year":"2020","journal-title":"J\u00a0Infect Dis"},{"issue":"35","key":"10.1016\/j.clp.2024.10.008_bib58","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.vaccine.2022.07.026","article-title":"Modestly protective cytomegalovirus vaccination of young children effectively prevents congenital infection at the population level","volume":"40","author":"Byrne","year":"2022","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.clp.2024.10.008_bib59","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.clp.2024.10.008_bib60","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"issue":"9773","key":"10.1016\/j.clp.2024.10.008_bib61","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2024.10.008_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiad593","article-title":"Human cytomegalovirus mRNA-1647 vaccine candidate elicits potent and broad neutralization and higher antibody-dependent cellular cytotoxicity responses than the gB\/MF59 vaccine","author":"Hu","year":"2024","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.clp.2024.10.008_bib63","first-page":"ofad500","article-title":"2892. safety and immunogenicity of mRNA-1647, an mRNA-based cytomegalovirus vaccine in healthy adults: results of a phase 2, randomized, observer-blind, placebo-controlled, dose-finding trial","volume":"10","author":"Panther","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clp.2024.10.008_bib64","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ofid\/ofab466.1242","article-title":"Double-blind, randomized, placebo-controlled phase 2b multicenter trial of V160, a replication-defective human cytomegalovirus (CMV) vaccine","volume":"8","author":"Das","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.clp.2024.10.008_bib65","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.vaccine.2023.12.019","article-title":"An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: a first-in-humans Canadian Immunization Research Network (CIRN) study","volume":"42","author":"Langley","year":"2024","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.clp.2024.10.008_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16122211","article-title":"Comparison of risk for end-stage renal disease between physicians and the general population: a nationwide population-based cohort study","volume":"16","author":"Yen","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.clp.2024.10.008_bib70","unstructured":"Cytomegalovirus, SB 1060, 64th Legislature of the State of Idaho, First Regular Session, 2017 sess (2017)."},{"key":"10.1016\/j.clp.2024.10.008_bib76","author":"Rosenthal"},{"key":"10.1016\/j.clp.2024.10.008_bib85","article-title":"Minnesota becomes first state to screen all newborns for congenital cytomegalovirus","author":"Schultz","year":"2024","journal-title":"MN Department of Public Health"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510824001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510824001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:13:20Z","timestamp":1749723200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510824001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0095510824001088"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2024.10.008","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neonatal Cytomegalovirus Infection","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2024.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}